Chapter 1.GLOBAL MEDICAL CANNABIS MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.GLOBAL MEDICAL CANNABIS MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 - 2030

      2.3.2. Impact on Supply – Demand

Chapter 3.GLOBAL MEDICAL CANNABIS MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.GLOBAL MEDICAL CANNABIS MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. GLOBAL MEDICAL CANNABIS MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.GLOBAL MEDICAL CANNABIS MARKET – By Product

6.1. Flower

6.2. Oil & Tinctures

Chapter 7.GLOBAL MEDICAL CANNABIS MARKET – By Application

7.1. Cancer

7.2. Chronic Pain

7.3. Depression and Anxiety

7.4. Arthritis

7.5. Diabetes

7.6. Glaucoma

7.7. Migraines

7.8. Epilepsy

7.8. Multiple Sclerosis

7.9. AIDS

7.11. Amyotrophic Lateral Sclerosis

7.12. Alzheimer’s Disease

7.13. Post-Traumatic Stress Disorder (PTSD)

7.14. Parkinson's Disease

7.15. Tourette

Chapter 8.GLOBAL MEDICAL CANNABIS MARKET – By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. The Middle East

8.6. Africa

Chapter 9. GLOBAL MEDICAL CANNABIS MARKET – Key players

9.1. Cara Therapeutics Inc.

9.2. Cannabis Sativa, Inc.

9.3. CannaGrow Holdings, Inc.

9.4. United Cannabis Corporation

9.5. Growblox Sciences, Inc.

9.6. GreenGro Technologies, Inc.

9.7. GW Pharmaceuticals plc

9.8. International Consolidated Companies, Inc.

9.9. Lexaria Corp